22-50603225-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012324.6(MAPK8IP2):c.174C>A(p.Asp58Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012324.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAPK8IP2 | NM_012324.6 | c.174C>A | p.Asp58Glu | missense_variant, splice_region_variant | 3/12 | ENST00000329492.6 | NP_036456.1 | |
MAPK8IP2 | XM_011530679.3 | c.174C>A | p.Asp58Glu | missense_variant, splice_region_variant | 3/12 | XP_011528981.1 | ||
MAPK8IP2 | XM_011530680.3 | c.174C>A | p.Asp58Glu | missense_variant, splice_region_variant | 3/12 | XP_011528982.1 | ||
MAPK8IP2 | XM_011530681.3 | c.174C>A | p.Asp58Glu | missense_variant, splice_region_variant | 3/12 | XP_011528983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAPK8IP2 | ENST00000329492.6 | c.174C>A | p.Asp58Glu | missense_variant, splice_region_variant | 3/12 | 1 | NM_012324.6 | ENSP00000330572.4 | ||
MAPK8IP2 | ENST00000008876.7 | n.93C>A | non_coding_transcript_exon_variant | 1/10 | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2024 | The c.174C>A (p.D58E) alteration is located in exon 3 (coding exon 3) of the MAPK8IP2 gene. This alteration results from a C to A substitution at nucleotide position 174, causing the aspartic acid (D) at amino acid position 58 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.